Influence of decavanadate on rat synaptic plasma membrane ATPases activity by Krstić, Danijela Z. et al.
302 Gen. Physiol. Biophys. (2009), 28, 302–308
doi:10.4149/gpb_2009_03_302
Influence of decavanadate on rat synaptic plasma membrane ATPases 
activity
Danijela Krstić1, Mirjana Čolović2, Nada Bošnjaković-Pavlović3, Anne Spasojević-De Bire4 
and VesnaVasić2
1 Institute of Medicinal Chemistry, University School of Medicine, Belgrade, Serbia
2 Department of Physical Chemistry, Vinča Institute of Nuclear Sciences, Belgrade, Serbia
3 Faculty of Physical Chemistry, University of Belgrade, Serbia
4 Ecole Centrale Paris, Laboratoire SPMS UMR CNRS 85801, Grande Voie des Vignes, 92295 Châtenay-Malabry, France
Abstract. The in vitro influence of decameric vanadate species on Na+/K+-ATPase, plasma mem-
brane Ca2+-ATPase (PMCA)-calcium pump and ecto-ATPase activity, using rat synaptic plasma 
membrane (SPM) as model system was investigated, whereas the commercial porcine cerebral cortex 
Na+/K+-ATPase served as a reference. The thermal behaviour of the synthesized decavanadate (V10) 
has been studied by differential scanning calorimetry and thermogravimetric analysis, while the 
type of polyvanadate anion was identified using the IR spectroscopy. The concentration-dependent 
responses to V10 of all enzymes were obtained. The half-maximum inhibitory concentration (IC50) 
of the enzyme activity was achieved at (4.74 ± 1.15) × 10–7 mol/l for SPM Na+/K+-ATPase, (1.30 
± 0.10) × 10–6 mol/l for commercial Na+/K+-ATPase and (3.13 ± 1.70) × 10–8 mol/l for Ca2+-ATPase, 
while ecto-ATPase is significantly less sensitive toward V10 (IC50 = (1.05 ± 0.10) × 10–4 mol/l) than 
investigated P-type ATPases. Kinetic analysis showed that V10 inhibited Na+/K+-ATPase by reducing 
the maximum enzymatic velocity and apparent affinity for ATP (increasing Km value), implying a 
mixed mode of interaction between V10 and P-type ATPases.
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Introduction
Interest in the interaction of vanadate oxoanions with bio-
logical systems has increased since it has been demonstrated 
to have a variety of physiological effects acting either as a 
phosphate analogue in the monomeric form (H2VO4–) (Can-
tley et al. 1977) or through oligomeric (dimeric, tetrameric 
and decameric) vanadate species which interact with many 
biomolecules with various and versatile activity (enzymes 
inhibitor or activator). Recent data indicate spermicidal 
and anti-HIV activity of vanadium compounds (D’Cruz et 
al. 2003) and the use of these compounds for the treatment 
of diabetes (Heinemann et al. 2003; Sakurai et al. 2004; Yang 
et al. 2004) as well as the prevention of animal carcinogens 
(Kanna et al. 2004; Molinuevo et al. 2004). It was reported 
that decavanadate (V10) is the major protein-bound species 
of vanadium and have a stronger effect on various enzymes, 
when compared to other vanadate oligomers (Aureliano and 
Gândara 2005). Recently reported V10 studies include the 
possibility of its use as a tool in the understanding of the 
transducing chemical energy into conformational energy 
for Ca2+ transport by Ca2+-ATPase (Stokes et al. 2005) as 
well as molecular mechanism of muscle contraction (Tiago 
et al. 2004). Inhibitions of several adenosine triphosphatases 
(ATPases) such as P-type ATPases, ABC-ATPases and ri-
bonucleases by V10 suggest that V10 interactions with these 
proteins probably favored by the existence of an ATP binding 
site (Messmore and Raines 2000; Pezza et al. 2002).
Na+/K+-ATPase (sodium pump) and plasma membrane 
Ca2+-ATPase (PMCA)-calcium pump belong to the P-type 
ATPase family, the members of which are able to utilize the 
energy of ATP to transport ions against their electrochemi-
cal gradient across membrane and strongly inhibited by 
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nanomolar concentration of orthovanadate (Cantley et al. 
1977).
Na+/K+-ATPase is a cell membrane located enzyme that 
establishes and maintains the high internal K+ and low 
internal Na+ concentrations, characteristic and essential 
for normal cellular activities of most animal cells (Vasilets 
and Schwarz 1993; Rodriguez de Lores Arnaiz and Pena 
1995). The activity of this enzyme is very sensitive to the 
presence of some metal ions and organic compounds of 
various structures, especially some drugs and pesticides 
(Blasiak 1995; Krstić et al. 2004, 2005). PMCA is a fine 
tuner of cytosolic calcium concentration in excitable cells, 
while the calcium pump is the sole system responsible 
for extrusion of calcium ions outside nonexcitable cells 
(Zylinska and Soszynski 2000). The ecto-ATPase, which 
does not belong to the P-type ATPase family, represents 
an integral membrane protein that, in the presence of 
divalent cations (Ca2+ or Mg2+), hydrolyses extracellular 
nucleotides because of the outward orientation of its active 
site (Nagy 1986). By hydrolysing ATP to ADP, ecto-ATPase 
represents the major inactivating agent in purine-triphos-
phate signalling (Horvat et al. 2006). The aim of this work 
was the investigation of the in vitro effect of ammonium 
V10, (NH4)6V10O28·5H2O on Na+/K+-ATPase (sodium 
pump), PMCA-calcium pump and ecto-ATPase (Mg2+-
ATPase) activity, using rat synaptic plasma membrane 
(SPM) as a model system, while the commercial porcine 
cerebral cortex Na+/K+-ATPase served as a reference. In 
addition, extensive kinetic studies of porcine cerebral cortex 
Na+/K+-ATPase were undertaken to determine the nature 
of enzyme inhibition by V10. These enzymes were chosen 
because of their key role in normal functioning most cells 
of higher eukaryotic organisms (Scheiner-Bobis 2002) as 
well as pivotal roles in cancer cell migration (Lefranc et al. 
2008) and, on the other hand, known influence of V10 on 
nucleotide-dependent enzymes (Boyd et al. 1985; Csermely 
et al. 1985; Varga et al. 1985; Aureliano 2000; Pezza et al. 
2002; Aureliano and Gândara 2005).
Materials and Methods
Chemicals
All chemicals were of analytical grade. Na+/K+-ATPase 
from porcine cerebral cortex and ATP were purchased 
from Sigma Co., as well as some chemicals for medium 
assay (magnesium chloride and Tris-HCl). The specific 
Na+/K+-ATPase activity was 25.8 μmol Pi/h/mg protein 
(Pi – inorganic orthophosphate). Other medium as-
say chemicals (sodium chloride, potassium chloride), 
chemicals for determination of Pi (stannous chloride and 
ammonium molybdate) and ammonium trioxovanadate 
(NH4VO3) used for synthesis were from Merck (Darm-
stadt, Germany).
Synthesis of ammonium V10
The title compound, (NH4)6V10O28·5H2O, was prepared 
by dissolving NH4VO3 (0.4 g, 3.42 mmol) in distilled water 
(20 ml) as described in Chinea et al. (2000) to obtain V10 
anions. The solution was stirred and heated until complete 
dissolution of NH4VO3 (about 2 h). The pH was adjusted 
to 5.90 by dropwise addition of NH4OH. Orange crystals 
were formed within four days from the solution, kept at 
room temperature.
Thermal studies
Thermal analysis was performed on Instruments model 
SDT 2960 Simultaneous DSC-TGA (differential scanning 
calorimetry-thermogravimetric analysis) under following 
conditions: air atmosphere, sample mass 100 mg, heating 
rate 10°C·min–1, temperature interval 20–700°C.
Infrared (IR) spectroscopy
The IR spectra in pastille was recording on Thermo Scientific 
spectrometer Nicolet 6700FT-IC, at room temperature, in 
the range 450–4000 cm–1. The solid compound was mixed 
with potassium bromide into transparent disk.
Preparation of V10 solution
Ammonium V10 stock solution (10 mmol/l) was prepared 
by diluting 117.3 mg of V10 in 10 ml of water and held in 
refrigerator until use. Working solutions were prepared daily 
by diluting stock solution to desired concentrations.
SPM preparation
SPM were isolated from the whole brain of 3-month-old 
male Wistar albino rats from the local colony. Animals were 
kept under controlled illumination (lights on: 5:00 a.m.–5:00 
p.m.) and temperature (23 ± 2ºC), and had free access to 
food and water. The Guiding Principles for the Care and 
Use of Animals based upon Helsinki Declaration (1964) 
and Protocol of the “Vinča” Institute on Care and Treat-
ment of Laboratory Animals were strictly followed. After 
decapitation with a guillotine (Harvard Apparatus), brains 
were rapidly excised and pooled (6/pool) for immediate 
preparation of SPM isolated according to the method of 
Cohen et al. (1977), as modified by Towle and Sze (1983). 
The mitochondrial contamination and protein content were 
determined according to the standard procedure (Nikezić et 
al. 1998.) SPM were stored at –70ºC until used.
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ATPase assays
The standard assay medium for investigation of Na+/K+-AT-
Pase activity contained (in mmol/l): 50 Tris-HCl (pH 7.4), 
100 NaCl, 20 KCl, 5 MgCl2, 2 ATP and 125 mg/l SPM 
proteins (i.e. 290 mg/l commercial porcine cerebral cortex 
proteins) while the rat synaptic PMCA activity was assayed 
in standard medium containing (in mmol/l): 50 Tris-HCl 
(pH 7.4), 0.5 EGTA, 0.5 CaCl2, 5 MgCl2, 2 ATP and 125 
mg/l SPM proteins in a final volume of 200 μl. Assay for SPM 
ecto-ATPase activity contained (in mmol/l): 50 Tris-HCl 
(pH 7.4), 5 MgCl2, 2 ATP and 125 mg/l SPM proteins. After 
preincubation for 10 min at 37ºC in the absence (control) 
or in the presence of investigated compound, the reaction 
was initiated by addition of ATP and stopped after 10 min 
by adding 22 μl ice cold of 3 mol/l HClO4 and immediate 
cooling on ice. The released Pi liberated from the hydrolysis 
of ATP was determined by a modified spectrophotometric 
method (Vasić et al. 1999). The spectrophotometric measure-
ments were performed on a Perkin Elmer Lambda 35 UV 
VIS spectrophotometer. The activity obtained in the presence 
of Mg2+ alone was attributed to ecto-ATPase activity. SPM 
Na+/K+-ATPase as well as SPM Ca2+-ATPase activities were 
calculated by subtracting the Mg2+-ATPase (ecto-ATPase) 
activity from the total ATPase activity in the presence of 
Na+, K+ and Mg2+ ions (i.e. in the presence of Ca2+ and 
Mg2+ ions). The results are expressed as mean percentage 
enzyme activity compared to the corresponding control 
value ± S.E.M. of at least three independent experiments 
done in triplicate.
Kinetic analysis
Kinetic experiments were carried out according to the 
slightly modified method of Philips (Philips et al. 1978) 
using the commercial porcine cerebral cortex Na+/K+-
ATPase. The initial velocities were measured in the same 
incubation medium as a function of rising concentrations 
of MgATP2– (0.1–5.0 mmol/l). The measurements were 
performed in the absence and presence of V10, while 
maintaining the concentrations of other ions (Na+, K+ 
and Mg2+) constant. The experimental data were fitted to 
the Michaelis-Menten equation by nonlinear regression 
analysis using EZ-FIT program (Perrella 1988). Maxi-
mum enzymatic velocity (Vmax) and Michaelis constant 
(Km) values were derived by nonlinear regression fitting 
(hyperbola function) of the experimental data as well 
as from a Lineweaver-Burk plot and expressed in μmol 
Pi/h/mg protein and mmol/l of ATP. Results are given as 
means ± S.E.M.
Results
Thermal studies
Thermal decomposition of ammonium V10 starts at 85°C, 
and proceeds as a more step process (Fig. 1). All endo- and 
exothermic effects are connected with weight changes. The 
first endothermic step corresponds to the loss of the crys-
tallization water molecules (85–155°C). This crystal form is 
stable up to 175°C. This step corresponds to the weight loss 
about 8% and to the departure of about five water molecules 
per V10. After this temperature, there are an endothermic 
step (180–300°C) and another exothermic step (330–400°C). 
They correspond to exothermic processes arising from the 
combustion of organic groups. At about 400°C, the thermo-
stable form, V2O5, was formed. Thermogravimetric analysis 
curves show that the synthesized V10 contains 5 molecules 
of water at room temperature.
IR spectra
The IR spectroscopy is a good method of identification of the 
type of polyvanadate anion as the structures of these anions 
are relatively rigid. They are only slightly influenced by the 
nature of cation and by hydrogen bonds between cation 
and anion or between crystal water and anion, respectively. 
Therefore, the synthesized compound could be identified 
based on their IR spectra (Fig. 2).
The IR spectra of the synthesized V10 contains the bands 
which are characteristic for the groups: NH4+, OH– and V-O. 
The characteristic bands for NH4+ is at 1400 cm–1, bending, 
and for OH– at about 1607 cm–1. In the 450–1000 cm–1 
region the IR spectra of the V10 exhibits bands correspond-
ing to V-Ot stretching at 950 cm–1 and to V-Ob stretching 
at 809 cm–1, all of them with position characteristic for V10 
(Escobar and Baran 1981).
Figure 1. Thermogravimetric analysis (line 1) and differential scan-
ning calorimetry (line 2) curves for the thermal decomposition of 
compound (NH4)6V10O28·5H2O.
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The in vitro influence of V10 on SPM ATPase activity
The influence of V10 on SPM ATPases and commercial porcine 
cerebral cortex Na+/K+-ATPase activity was investigated by 
in vitro exposure to the enzymes in the concentration range 
from 1 × 10–10 to 1 × 10–3 mol/l. The results show that increas-
ing concentrations of V10 induce inhibition of enzymatic activ-
ity in a concentration-dependent manner in all cases (Fig. 3a). 
The dependence of enzyme activity, expressed as a percentage 
of the control value (obtained without inhibitor), on inhibitor 
concentration fits a sigmoidal function (Eq. (1)) for all enzymes. 
The half-maximum inhibitory concentrations (IC50) of the 
investigated compound for all ATPases were determined by 
sigmoidal fitting the experimental results as well as by Hill 
analysis (Eq. (2); Fig. 3b) and are summarized in Table 1.
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where n is Hill’s coefficient and [I] is inhibitor (V10) con-
centration.
All the parameters of both used equations are reported in 
Table 1. It is clearly apparent that plasma membrane calcium 
and sodium pumps (SPM ATPases and commercial porcine 
cerebral cortex) are more sensitive toward V10 anion than 
ecto-ATPase. At the concentration of 1 × 10–5 mol/l V10 
inhibits both SPM and commercial Na+/K+-ATPase as well 
as Ca2+-ATPase up to 80%, while the effect of the same con-
centration of V10 on the ecto-ATPase activity is negligible. 
IC50 of the enzyme activity is achieved at (4.74 ± 1.15) × 10–7 
mol/l for SPM Na+/K+-ATPase, (1.30 ± 0.10) × 10–6 mol/l for 
commercial Na+/K+-ATPase and (3.13 ± 1.70) × 10–8 mol/l 
for Ca2+-ATPase, while the same effect for ecto-ATPase is 
Figure 2. IR spectra (tansmittance (T) dependence on vawenumber 
(ν)) of (NH4)6V10O28·5H2O recorded at room temperature.
Figure 3. The concentration dependent (a) and Hill analysis (b) inhibition of SPM Na+/K+-ATPase (square), Ca2+-ATPase (circle), Mg2+-ATPase 
(triangle) and commercial porcine cerebral cortex Na+/K+-ATPase (inset) by ammonium decavanadate (V10). CV10, concentration of V10.
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observed at several orders of magnitude higher concentration 
of V10: (1.05 ± 0.10) × 10–4 mol/l.
Kinetic analysis
To evaluate the nature of the P-type ATPases inhibition by 
V10, the kinetic parameters of commercial porcine cerebral 
cortex Na+/K+-ATPase, Km and Vmax, were determined by 
varying the concentration of MgATP2–. The kinetic prop-
erties of the enzyme were determined in the absence and 
presence of IC50 of V10 (1.30 × 10–6 mol/l). The depend-
ence of the initial reaction rate vs. substrate concentration 
in the presence and absence of inhibitor exhibited typical 
Michaelis-Menten kinetics, and is presented in Fig. 4. Ki-
netic constants were calculated from the experimental data 
by nonlinear regression fitting (hyperbola function) as well 
as Lineweaver-Burk transformation (Fig. 4, inset), and are 
summarized in Table 2. Km and Vmax values obtained by 
nonlinear regression fitting are in good agreement with 
values obtained by linear fitting model. As can be seen, V10 
induced mixed type of inhibition of Na+/K+-ATPase activity 
by significant decreasing its maximal velocity (Vmax value), 
as well as decreasing its apparent affinity for ATP (increased 
Km value).
Discussion
In the present study we investigated the effect of vanad-
ate decamer on the activity of rat synaptosomal plasma 
membrane ATPases. Vanadium solution contains different 
oligomeric (n = 1–10) vanadate species in equilibrium, e.g., 
monomeric, dimeric, tetrameric and decameric and, with 
different states of protonation and conformation, depending 
of the pH (Tiago et al. 2004). The acidification from pH 7 to 
pH 5 leads to the formation of yellow solution containing the 
V10 core [V10O28]6–, which can be found in several protona-
tion states [H2V10O28]4– [H3V10O28]3– and [H4V10O28]2–. 
Table 1. The inhibition parameters of the ATPases inhibition by of ammonium V10 obtained by fitting the experimental points by sigmoidal 
function and Hill analysis
Sigmoidal fitting Hill analysis
A1 A2 p
IC50 (x0)
(mol/l) n
IC50
(mol/l)
Na+/K+-ATPase  99.11  –0.08 0.75 ± 0.14 (4.74 ± 1.15) × 10–7 0.81 ± 0.13 4.79 × 10–7
Ca2+-ATPase  104.59  6.41 0.44 ± 0.11 (3.13 ± 1.70) × 10–8 0.46 ± 0.05 4.68 × 10–8
Mg2+-ATPase  99.61  10.85 1.55 ± 0.33 (1.05 ± 0.10) × 10–4 1.08 ± 0.11 1.58 × 10–4
Commercial 
Na+/K+-ATPase  101.99  7.94 0.94 ± 0.06 (1.30 ± 0.10) × 10
–6 0.88 ± 0.03 1.71 × 10–6
A1, A2, p – parameters of sigmoidal function; IC50, half-maximum inhibitory concentration of the enzyme activity; IC50 (x0), IC50 de-
termined by sigmoidal fitting; n, Hill’s coefficiet.
Table 2. Kinetic analysis of commercial porcine cerebral cortex 
Na+/K+-ATPase activity in the absence and presence of V10 (1.30 
× 10–6 mol/l)
Control V10
Km (mmol/l) 1.68 ± 0.14* 2.38 ± 0.20*
1.76 ± 0.02** 2.69 ± 0.09**
Vmax (μmol Pi /h/mg) 59.93 ± 2.02* 39.65 ± 1.72*
61.13 ± 1.75** 41.87 ± 1.35**
V10, decavanadate; Km, Michaelis constant; Vmax, maximum 
enzymatic velocity; Pi, inorganic phosphate; * values obtained by 
Lineweaver-Burk transformation; ** values obtained by nonlinear 
regression fitting-hyperbola function.
Figure 4. Na+/K+-ATPase specific activity (expressed as initial 
velocity v0) dependence on MgATP2– in the absence (square) and 
presence (circle) of 1 × 10–6 mol/l V10. The experimental conditions 
are described in Materials and Methods. The values (expressed as 
μmol released inorganic phosphate (Pi)) given are the mean of at least 
three experiments ± S.E.M., conducted in duplicate. The Lineweav-
er-Burk transformation of the data is shown in the inset.
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In this kind of compound, the location of the protons is 
important because of the basic role played by the oxygen sites 
in the reactivity of the polyanion. Obtained IR spectra of the 
synthesized vanadate decamer (Fig. 2) exhibits bands with 
position characteristic for non-protonated V10 anion.
The obtained results (Table 1 and Fig. 3) show that V10 
exhibits concentration-dependent inhibitory effect on the 
activity of all investigated enzymes. These results are in agree-
ment with previously reported findings that V10 oxoanion 
inhibits several nucleotide-dependent enzymes (Boyd et al. 
1985; Aureliano et al. 2000), although the data about decav-
anate influence on plasma membrane ATPases are scant.
The sensitivity of investigated ATPases toward vanad-
ate decamer, as shown in our study, is quite different. It is 
obvious that PMCA is the most sensitive toward V10 anion 
(Table 1). Moreover, obtained inhibitory parameters for V10 
show that PMCA is two orders of magnitude more sensitive 
than sarcoplasmic reticulum Ca2+-ATPase from rabbit skel-
etal muscles (Varga et al. 1985). Both SPM and commercial 
sodium pumps are about one order of magnitude less sensi-
tive than PMCA, while the activity of ecto-ATPase is about 
thousand times more resistant to V10 anion than investigated 
P-type ATPases. These results are in agreement with previ-
ously reported data, that SPM ecto-ATPase from rat brain is 
significantly less sensitive toward different metal ions than 
Na+/K+-ATPase (Vasić et al. 1999; Krstić et al. 2005).
Kinetic analysis of the results shows that the presence 
of V10 induces significant decrease in Vmax and increase in 
Km values of Na+/K+-ATPase (Table 2) related to control. 
Moreover, different points of intersection of straight lines 
with x-axis and y-axis obtained from Lineweaver-Burk 
analysis of the kinetic data in the absence and presence of 
V10 confirm mixed mode of interaction (Fig. 4, inset). It 
indicates that V10 as a reversible mixed inhibitor of Na+/K+-
ATPase activity binds to enzyme sites participating in both 
substrate binding and catalysis. Obtained mixed inhibition 
is in agreement with previously reported results that there 
are two binding sites for V10 on Ca2+-ATPase which belongs, 
as well as Na+/K+-ATPase, to P-type of ATPases (Varga et 
al. 1985; Stokes et al. 2005). Decrease in apparent affinity 
for MgATP2– is in agreement with competition of V10 with 
fluorescein isothocyanate for ATP binding site of Ca2+-AT-
Pase (Csermely et al. 1985). Obtained decrease in maximal 
velocity of the enzyme reaction probably can be explained 
by binding of V10 to another binding site that is, as earlier 
reported (Csermely et al. 1985), binding site for inorganic 
phosphate on Ca2+-ATPase.
It could be summarized that the obtained dose-depend-
ent inhibition of PMCA and sodium pump by V10, as well 
as kinetic analysis, is in agreement with previously reported 
findings that decameric vanadate species block the active side 
of P-type ATPases and consequently affect phosphorylation 
step in the enzyme cycle of P-type ATPases (sodium and 
calcium pump) (Stokes et al. 2005). However, this mechanism 
could not be responsible for obtained ecto-ATPase inhibition 
(a member of ecto-NTPDases) and probably occurs via dif-
ferent mechanism resulting in less sensitivity compared to 
P-type ATPases (sodium and calcium pump).
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